Further, 19 of 62 cancer patient-derived PTEN missense mutations in the phosphatase domain mapped to the proposed p85α interaction surface (Figure 6—figure supplement 1D), suggesting that additional PTEN mutations may function through disrupting the association of PTEN with p85α. The gene discussed is PTEN; the disease is cancer.